Literature DB >> 26276001

Research using Mesenchymal Stem/Stromal Cells: quality metric towards developing a reference material.

Vivek Tanavde1, Candida Vaz2, Mahendra S Rao3, Mohan C Vemuri4, Radhika R Pochampally5.   

Abstract

Mesenchymal stem/stromal cells (MSCs) have been extensively investigated for their regenerative, immune-modulatory, and wound healing properties. While the laboratory studies have suggested that MSC's have a unique potential for modulating the etiopathology of multiple diseases, the results from clinical trials have not been encouraging or reproducible. One of the explanations for such variability is explained by the "art" of isolating and propagating MSCs. Therefore, establishing more than minimal criteria to define MSC would help understand best protocols to isolate, propagate and deliver MSCs. Developing a calibration standard, a database and a set of functional tests would be a better quality metric for MSCs. In this review, we discuss the importance of selecting a standard, issues associated with coming up with such a standard and how these issues can be mitigated.
Copyright © 2015 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2015        PMID： 26276001      PMCID： PMC4943322          DOI： 10.1016/j.jcyt.2015.07.008

Source DB:  PubMed          Journal:  Cytotherapy        ISSN： 1465-3249            Impact factor:   5.414


  43 in total

1.  Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord.

Authors:  Hwai-Shi Wang; Shih-Chieh Hung; Shu-Tine Peng; Chun-Chieh Huang; Hung-Mu Wei; Yi-Jhih Guo; Yu-Show Fu; Mei-Chun Lai; Chin-Chang Chen
Journal:  Stem Cells       Date:  2004       Impact factor: 6.277

Review 2.  Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views.

Authors:  Donald G Phinney; Darwin J Prockop
Journal:  Stem Cells       Date:  2007-09-27       Impact factor: 6.277

Review 3.  The decision on the "optimal" human pluripotent stem cell.

Authors:  Margit Rosner; Katharina Schipany; Markus Hengstschläger
Journal:  Stem Cells Transl Med       Date:  2014-04-01       Impact factor: 6.940

4.  Stat5a/b contribute to interleukin 7-induced B-cell precursor expansion, but abl- and bcr/abl-induced transformation are independent of stat5.

Authors:  V Sexl; R Piekorz; R Moriggl; J Rohrer; M P Brown; K D Bunting; K Rothammer; M F Roussel; J N Ihle
Journal:  Blood       Date:  2000-09-15       Impact factor: 22.113

Review 5.  Concise review: Mesenchymal stem cells for acute lung injury: role of paracrine soluble factors.

Authors:  Jae W Lee; Xiaohui Fang; Anna Krasnodembskaya; James P Howard; Michael A Matthay
Journal:  Stem Cells       Date:  2011-06       Impact factor: 6.277

Review 6.  Human bone marrow mesenchymal stem cells in vivo.

Authors:  E Jones; D McGonagle
Journal:  Rheumatology (Oxford)       Date:  2007-11-06       Impact factor: 7.580

Review 7.  Systematic review and meta-analysis of mesenchymal stem/stromal cells therapy for impaired renal function in small animal models.

Authors:  Yan Wang; Juan He; Xiaohua Pei; Weihong Zhao
Journal:  Nephrology (Carlton)       Date:  2013-03       Impact factor: 2.506

8.  Multiparameter Analysis of Human Bone Marrow Stromal Cells Identifies Distinct Immunomodulatory and Differentiation-Competent Subtypes.

Authors:  Sally James; James Fox; Farinaz Afsari; Jennifer Lee; Sally Clough; Charlotte Knight; James Ashmore; Peter Ashton; Olivier Preham; Martin Hoogduijn; Raquel De Almeida Rocha Ponzoni; Y Hancock; Mark Coles; Paul Genever
Journal:  Stem Cell Reports       Date:  2015-06-09       Impact factor: 7.765

9.  Aberrant expression of interleukin-7 (IL-7) and its signalling complex in human breast cancer.

Authors:  M A A Al-Rawi; K Rmali; G Watkins; R E Mansel; W G Jiang
Journal:  Eur J Cancer       Date:  2004-03       Impact factor: 9.162

Review 10.  Paracrine effects of stem cells in wound healing and cancer progression (Review).

Authors:  Jürgen Dittmer; Benjamin Leyh
Journal:  Int J Oncol       Date:  2014-04-11       Impact factor: 5.650
View more
  15 in total

1.  Potency Analysis of Mesenchymal Stromal Cells Using a Phospho-STAT Matrix Loop Analytical Approach.

Authors:  Raghavan Chinnadurai; Augustine Rajakumar; Andrew J Schneider; Wade A Bushman; Peiman Hematti; Jacques Galipeau
Journal:  Stem Cells       Date:  2019-06-03       Impact factor: 6.277

2.  Potency Analysis of Mesenchymal Stromal Cells Using a Combinatorial Assay Matrix Approach.

Authors:  Raghavan Chinnadurai; Devi Rajan; Muna Qayed; Dalia Arafat; Marco Garcia; Yifei Liu; Subra Kugathasan; Larry J Anderson; Greg Gibson; Jacques Galipeau
Journal:  Cell Rep       Date:  2018-02-27       Impact factor: 9.423

3.  Lentiviral-based reporter constructs for profiling chondrogenic activity in primary equine cell populations.

Authors:  A Martin-Pena; R M Porter; G Plumton; T M McCarrel; A J Morton; M V Guijarro; S C Ghivizzani; B Sharma; G D Palmer
Journal:  Eur Cell Mater       Date:  2018-10-12       Impact factor: 3.942

4.  Amniotic Mesenchymal Stromal Cells Exhibit Preferential Osteogenic and Chondrogenic Differentiation and Enhanced Matrix Production Compared With Adipose Mesenchymal Stromal Cells.

Authors:  Natasha Topoluk; Richard Hawkins; John Tokish; Jeremy Mercuri
Journal:  Am J Sports Med       Date:  2017-05-25       Impact factor: 6.202

5.  Variation in primary and culture-expanded cells derived from connective tissue progenitors in human bone marrow space, bone trabecular surface and adipose tissue.

Authors:  Maha A Qadan; Nicolas S Piuzzi; Cynthia Boehm; Wesley Bova; Malcolm Moos; Ronald J Midura; Vincent C Hascall; Christopher Malcuit; George F Muschler
Journal:  Cytotherapy       Date:  2018-02-01       Impact factor: 5.414

6.  The immunomodulatory properties of human bone marrow-derived mesenchymal stromal cells are defined according to multiple immunobiological criteria.

Authors:  Hussein Fayyad-Kazan; Wissam H Faour; Bassam Badran; Laurence Lagneaux; Mehdi Najar
Journal:  Inflamm Res       Date:  2016-03-08       Impact factor: 4.575

Review 7.  Reporting Guidelines, Review of Methodological Standards, and Challenges Toward Harmonization in Bone Marrow Adiposity Research. Report of the Methodologies Working Group of the International Bone Marrow Adiposity Society.

Authors:  Josefine Tratwal; Rossella Labella; Nathalie Bravenboer; Greet Kerckhofs; Eleni Douni; Erica L Scheller; Sammy Badr; Dimitrios C Karampinos; Sarah Beck-Cormier; Biagio Palmisano; Antonella Poloni; Maria J Moreno-Aliaga; Jackie Fretz; Matthew S Rodeheffer; Parastoo Boroumand; Clifford J Rosen; Mark C Horowitz; Bram C J van der Eerden; Annegreet G Veldhuis-Vlug; Olaia Naveiras
Journal:  Front Endocrinol (Lausanne)       Date:  2020-02-28       Impact factor: 5.555

8.  Polycomb group protein Suz12 is regulated by a novel miRNA-like small RNA.

Authors:  Patrice Penfornis; Joseph D Fernandes; Radhika R Pochampally
Journal:  Sci Rep       Date:  2018-01-29       Impact factor: 4.379

9.  Therapeutic Delivery Specifications Identified Through Compartmental Analysis of a Mesenchymal Stromal Cell-Immune Reaction.

Authors:  Matthew Li; Danika Khong; Ling-Yee Chin; Amy Singleton; Biju Parekkadan
Journal:  Sci Rep       Date:  2018-05-01       Impact factor: 4.379

Review 10.  Concise Reviews: Stem Cells and Kidney Regeneration: An Update.

Authors:  Julia Marcheque; Benedetta Bussolati; Marie Csete; Laura Perin
Journal:  Stem Cells Transl Med       Date:  2018-10-09       Impact factor: 6.940
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.